|Bid||0.00 x 1000|
|Ask||0.00 x 1200|
|Day's Range||19.08 - 21.96|
|52 Week Range||11.70 - 58.45|
|Beta (5Y Monthly)||2.71|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for ARCT
Shareholders in Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ) may be thrilled to learn that the analysts have...
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of 55.43% and 714.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zealand Pharma AS (ZEAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.